These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21876426)

  • 1. Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension.
    Luan Y; Zhang ZH; Wei DE; Zhao JJ; Kong F; Cheng GH; Wang YB
    Am J Med Sci; 2012 May; 343(5):402-6. PubMed ID: 21876426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
    Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
    Circulation; 2006 Jul; 114(1 Suppl):I181-5. PubMed ID: 16820570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.
    Lee H; Kim KC; Choi SJ; Hong YM
    Yonsei Med J; 2017 May; 58(3):570-580. PubMed ID: 28332363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
    Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
    Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor gene for the treatment of pulmonary hypertension in rats].
    Shang F; He ZX; Wang HW; Cui DB; Yang Y
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1847-51. PubMed ID: 22093789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Administrating bone marrow mesenchymal stem cells to treat the experimental pulmonary arterial hypertension in rats].
    He ZX; Wang HW; Shang F; Yan H; Yang Y
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2110-5. PubMed ID: 20058614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats.
    Yamaguchi T; Izumi Y; Yamazaki T; Nakamura Y; Sano S; Shiota M; Miura K; Iwao H; Yoshiyama M
    Osaka City Med J; 2015 Jun; 61(1):31-41. PubMed ID: 26434103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats.
    Takemiya K; Kai H; Yasukawa H; Tahara N; Kato S; Imaizumi T
    Basic Res Cardiol; 2010 May; 105(3):409-17. PubMed ID: 19838762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
    Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
    Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
    Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.
    Xie J; Hu D; Niu L; Qu S; Wang S; Liu S
    J Huazhong Univ Sci Technolog Med Sci; 2012 Dec; 32(6):810-817. PubMed ID: 23271278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism.
    Luan Y; Zhang X; Kong F; Cheng GH; Qi TG; Zhang ZH
    Int Immunopharmacol; 2012 Dec; 14(4):432-7. PubMed ID: 22922316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotaline-induced rat pulmonary hypertension.
    Jiang L; Song XH; Liu P; Zeng CL; Huang ZS; Zhu LJ; Jiang YZ; Ouyang HW; Hu H
    Cell Transplant; 2012; 21(7):1463-75. PubMed ID: 22525351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
    Jiang DT; Tuo L; Bai X; Bing WD; Qu QX; Zhao X; Song GM; Bi YW; Sun WY
    Stem Cell Res Ther; 2022 Jul; 13(1):316. PubMed ID: 35842683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats.
    Sun CK; Lee FY; Sheu JJ; Yuen CM; Chua S; Chung SY; Chai HT; Chen YT; Kao YH; Chang LT; Yip HK
    J Pharmacol Exp Ther; 2009 Sep; 330(3):718-26. PubMed ID: 19528354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart.
    Handoko ML; Lamberts RR; Redout EM; de Man FS; Boer C; Simonides WS; Paulus WJ; Westerhof N; Allaart CP; Vonk-Noordegraaf A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1752-9. PubMed ID: 19734361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
    Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
    Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.